Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Non Operating Income (2016 - 2025)

Mimedx (MDXG) has disclosed Non Operating Income for 11 consecutive years, with -$186000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income rose 10.58% to -$186000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$558000.0 through Dec 2025, up 1.24% year-over-year, with the annual reading at -$558000.0 for FY2025, 1.24% up from the prior year.
  • Non Operating Income hit -$186000.0 in Q4 2025 for Mimedx, down from -$126000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $16000.0 in Q4 2023 to a low of -$237000.0 in Q2 2024.
  • Historically, Non Operating Income has averaged -$78266.7 across 5 years, with a median of -$32000.0 in 2023.
  • Biggest five-year swings in Non Operating Income: skyrocketed 633.33% in 2023 and later crashed 5050.0% in 2024.
  • Year by year, Non Operating Income stood at -$20000.0 in 2021, then soared by 85.0% to -$3000.0 in 2022, then surged by 633.33% to $16000.0 in 2023, then tumbled by 1400.0% to -$208000.0 in 2024, then grew by 10.58% to -$186000.0 in 2025.
  • Business Quant data shows Non Operating Income for MDXG at -$186000.0 in Q4 2025, -$126000.0 in Q3 2025, and -$101000.0 in Q2 2025.